Ray Peat: RU486, Cancer, Estrogen, and Progesterone

References

1. Overexpression of wild-type p53 gene renders MCF-7 breast cancer cells more sensitive to the antiproliferative effect of progesteroneJ Endocrinol · 2003 · PMID 14529565
2. RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptorJ Clin Endocrinol Metab · 1985 · PMID 3972969
3. Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesteroneMol Carcinog · 2003 · PMID 14639655
4. Screening for antiproliferative actions of mifepristone. Differential endometrial responses of primates versus ratsContraception · 1998 · PMID 9743896
5. Modulation of oestrogenic effects by progesterone antagonists in the rat uterusHum Reprod Update · 1998 · PMID 10027611
6. Progesterone inhibits human infragenicular arterial smooth muscle cell proliferation induced by high glucose and insulin concentrationsJ Vasc Surg · 2002 · PMID 12368746
7. Emerging roles of BRCA1 in transcriptional regulation and DNA repairJ Cell Physiol · 1999 · PMID 10528224
8. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferationMol Endocrinol · 2005 · PMID 15845746
9. Regulation of steroidogenesis by p53 in macaque granulosa cells and H295R human adrenocortical cellsEndocrinology · 2004 · PMID 15331571
10. Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogensBreast Cancer Res Treat · 1994 · PMID 7532465
11. Inhibition of tumor induction in chemical carcinogenesis in the mammary glandProg Exp Tumor Res · 1971 · PMID 5166434
12. Gap junction communication dynamics and bystander effects from ultrasoft X-raysBr J Cancer · 2004 · PMID 15054470
13. Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude miceBreast Cancer Res Treat · 1998 · PMID 9696393
14. Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in cultureProstate · 2000 · PMID 10725863
15. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cellsBreast Cancer Res Treat · 1998 · PMID 9879777
16. Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 geneFEBS Lett · 2005 · PMID 16216245
17. TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1Mol Cell Biol · 2005 · PMID 15899840
18. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)Mol Endocrinol · 1997 · PMID 9328342
19. Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cellsEur J Cancer · 1996 · PMID 8695275
20. Non-competitive anti-oestrogenic activity of progesterone antagonists in primate modelsHum Reprod · 1994 · PMID 7962474
21. From chemical warfare to breast cancer managementNat Med · 2004 · PMID 15459693
22. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanismJ Biol Chem · 1994 · PMID 8163495
23. Effects of estrogens and progesterone on GABA system in ovariectomized rat retinaItal J Biochem · 1981 · PMID 7298312
24. Phenotypic features of breast cancer cells overexpressing ornithine-decarboxylaseJ Cell Physiol · 1995 · PMID 7896889
25. [Antiestrogens and normal human breast cell proliferation]Ann Endocrinol (Paris) · 1989 · PMID 2683973
26. Antiproliferative effects of low-dose micronized progesteroneFertil Steril · 1996 · PMID 8566256
27. Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNAClin Cancer Res · 1999 · PMID 10037189
28. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cellsCancer Res · 2000 · PMID 10728695

More references from this article

1. Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosisMol Cell Biochem · 1999 · PMID 10705995 · cited in Estrogen, progesterone, and cancer: Conflicts of interest in regulation and product promotion, Preventing and treating cancer with progesterone
2. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesteroneMol Cell Biol · 2006 · PMID 17015480 · cited in Estrogen, progesterone, and cancer: Conflicts of interest in regulation and product promotion, Preventing and treating cancer with progesterone
3. [Inhibitory effect of progesterone P1-1 on glutathione-s-transferase and its antiproliferative effect on human erythroleukemia K562 cells]Vopr Onkol · 2000 · PMID 10789228